Also trades as: 0M40.L (LSE) · $vol 0M
ZYNE NASDAQ
Zynerba Pharmaceuticals, Inc.
1W: +1.6%
1M: -3.7%
3M: +271.4%
1Y: +90.9%
3Y: -64.0%
5Y: -81.4%
$1.30
Last traded 2023-10-13 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships0
As Filer
counterparties named
3
As Counterparty
mentioned by others
2023-08-14
Earliest Filing
2023-10-11
Latest Filing
Mentioned As Counterparty
3 mentionsOther companies that named ZYNE in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings, Inc. | acquirer | Target company acquired in a merger transaction. | 2023-10-11 | View |
| HRMY Harmony Biosciences Holdings, Inc. | acquirer | Counterparty in Merger Agreement with Harmony Biosciences Holdings, Inc. | 2023-09-14 | View |
| HRMY Harmony Biosciences Holdings, Inc. | acquirer | Target company in a merger agreement with Harmony Biosciences Holdings, Inc. and its subsidiary Xylophone Acquisition Co | 2023-08-14 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR